Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Pancreatic Ductal | 23 | 2023 | 1510 | 3.170 |
Why?
|
Pancreatic Neoplasms | 32 | 2023 | 4980 | 2.670 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 14 | 2022 | 1634 | 2.330 |
Why?
|
ras Proteins | 2 | 2022 | 1102 | 1.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2022 | 2977 | 0.880 |
Why?
|
Protein Phosphatase 1 | 1 | 2022 | 143 | 0.870 |
Why?
|
Oncogenes | 4 | 2022 | 1246 | 0.850 |
Why?
|
Acetonitriles | 1 | 2021 | 51 | 0.840 |
Why?
|
MAP Kinase Signaling System | 6 | 2022 | 1571 | 0.800 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 150 | 0.750 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 192 | 0.720 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 515 | 0.710 |
Why?
|
Neoplasms | 17 | 2022 | 20528 | 0.580 |
Why?
|
Multiprotein Complexes | 1 | 2022 | 1162 | 0.560 |
Why?
|
Genomics | 6 | 2023 | 5342 | 0.540 |
Why?
|
Cell Line, Tumor | 26 | 2021 | 16736 | 0.520 |
Why?
|
Mutation | 18 | 2021 | 29291 | 0.520 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1311 | 0.510 |
Why?
|
Gene Expression Profiling | 11 | 2023 | 9504 | 0.500 |
Why?
|
Gene Dosage | 4 | 2016 | 1270 | 0.490 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2023 | 8571 | 0.460 |
Why?
|
Gene Targeting | 2 | 2016 | 902 | 0.460 |
Why?
|
Iron-Sulfur Proteins | 2 | 2022 | 84 | 0.450 |
Why?
|
Tumor Microenvironment | 8 | 2023 | 3054 | 0.440 |
Why?
|
Pyrimidines | 2 | 2021 | 2930 | 0.430 |
Why?
|
Colorectal Neoplasms | 5 | 2021 | 6592 | 0.410 |
Why?
|
Piperazines | 1 | 2021 | 2524 | 0.390 |
Why?
|
Adenocarcinoma | 10 | 2022 | 6324 | 0.360 |
Why?
|
Genes, ras | 3 | 2017 | 706 | 0.360 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2022 | 5198 | 0.360 |
Why?
|
Tumor Suppressor Protein p14ARF | 3 | 2006 | 92 | 0.340 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2720 | 0.330 |
Why?
|
Protein Kinase Inhibitors | 7 | 2022 | 5412 | 0.320 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2006 | 728 | 0.300 |
Why?
|
Lung Neoplasms | 7 | 2022 | 12539 | 0.290 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2020 | 2947 | 0.290 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 4912 | 0.270 |
Why?
|
raf Kinases | 2 | 2022 | 120 | 0.260 |
Why?
|
HCT116 Cells | 3 | 2021 | 408 | 0.260 |
Why?
|
Benzimidazoles | 2 | 2021 | 877 | 0.250 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 901 | 0.250 |
Why?
|
Signal Transduction | 8 | 2020 | 23729 | 0.240 |
Why?
|
Gene Knockout Techniques | 2 | 2017 | 809 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 6 | 2020 | 17409 | 0.240 |
Why?
|
Single-Cell Analysis | 4 | 2021 | 2129 | 0.240 |
Why?
|
Protein Stability | 2 | 2022 | 567 | 0.230 |
Why?
|
Haptens | 1 | 2022 | 184 | 0.230 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13626 | 0.230 |
Why?
|
Humans | 69 | 2023 | 715777 | 0.230 |
Why?
|
Genetic Variation | 1 | 2018 | 6664 | 0.220 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2022 | 11236 | 0.220 |
Why?
|
Crk-Associated Substrate Protein | 1 | 2021 | 42 | 0.220 |
Why?
|
Guanosine Triphosphate | 1 | 2022 | 328 | 0.210 |
Why?
|
Gene Regulatory Networks | 3 | 2021 | 1699 | 0.210 |
Why?
|
DNA Repair | 3 | 2021 | 2034 | 0.210 |
Why?
|
Cell Proliferation | 11 | 2021 | 10620 | 0.200 |
Why?
|
Nerve Tissue | 1 | 2021 | 75 | 0.200 |
Why?
|
Ameloblastoma | 1 | 2021 | 40 | 0.200 |
Why?
|
Nissl Bodies | 1 | 2020 | 17 | 0.200 |
Why?
|
Smad4 Protein | 1 | 2021 | 166 | 0.200 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3741 | 0.200 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2021 | 127 | 0.200 |
Why?
|
Jaw Neoplasms | 1 | 2021 | 76 | 0.200 |
Why?
|
src-Family Kinases | 2 | 2021 | 560 | 0.200 |
Why?
|
Mice, Hairless | 1 | 2019 | 45 | 0.190 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 118 | 0.190 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2023 | 471 | 0.190 |
Why?
|
Leucovorin | 1 | 2021 | 596 | 0.190 |
Why?
|
Pinocytosis | 1 | 2019 | 73 | 0.190 |
Why?
|
Amino Acid Motifs | 1 | 2022 | 967 | 0.190 |
Why?
|
Myeloid Cells | 2 | 2021 | 780 | 0.180 |
Why?
|
Codon | 1 | 2021 | 609 | 0.180 |
Why?
|
Animals | 30 | 2022 | 169420 | 0.180 |
Why?
|
Organoids | 3 | 2021 | 669 | 0.180 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1323 | 0.170 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 58 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 582 | 0.170 |
Why?
|
Neuregulin-1 | 1 | 2019 | 138 | 0.170 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 641 | 0.170 |
Why?
|
Cell-Penetrating Peptides | 1 | 2018 | 46 | 0.170 |
Why?
|
Enteric Nervous System | 1 | 2020 | 163 | 0.170 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 4647 | 0.170 |
Why?
|
Fusobacterium | 1 | 2017 | 53 | 0.170 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 397 | 0.160 |
Why?
|
Ketoglutarate Dehydrogenase Complex | 1 | 2017 | 22 | 0.160 |
Why?
|
Mice | 22 | 2022 | 80375 | 0.160 |
Why?
|
Neurosciences | 1 | 2022 | 323 | 0.160 |
Why?
|
GTP Phosphohydrolases | 1 | 2021 | 510 | 0.160 |
Why?
|
Mice, SCID | 2 | 2019 | 2787 | 0.150 |
Why?
|
Colonic Polyps | 1 | 2021 | 519 | 0.150 |
Why?
|
Metronidazole | 1 | 2017 | 204 | 0.150 |
Why?
|
Anilides | 1 | 2020 | 412 | 0.150 |
Why?
|
Fluorouracil | 1 | 2021 | 1610 | 0.150 |
Why?
|
DNA Cleavage | 1 | 2016 | 46 | 0.150 |
Why?
|
Lipid Peroxidation | 1 | 2017 | 312 | 0.150 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 672 | 0.140 |
Why?
|
Glutathione Peroxidase | 1 | 2017 | 261 | 0.140 |
Why?
|
Protein Conformation | 2 | 2021 | 4042 | 0.140 |
Why?
|
RNA Splicing | 1 | 2020 | 872 | 0.140 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2019 | 354 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 987 | 0.140 |
Why?
|
Genomic Instability | 1 | 2019 | 689 | 0.140 |
Why?
|
Cysteine | 1 | 2020 | 872 | 0.140 |
Why?
|
Genes, Essential | 1 | 2016 | 185 | 0.130 |
Why?
|
Microtubules | 1 | 2021 | 1208 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 986 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2021 | 3633 | 0.130 |
Why?
|
Antigens, Protozoan | 1 | 2017 | 314 | 0.130 |
Why?
|
Mutagenesis | 1 | 2018 | 1281 | 0.130 |
Why?
|
RNA, Guide | 1 | 2016 | 297 | 0.120 |
Why?
|
Inservice Training | 1 | 2016 | 402 | 0.120 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1727 | 0.120 |
Why?
|
DNA Damage | 3 | 2020 | 2434 | 0.120 |
Why?
|
Binding Sites | 1 | 2022 | 6214 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2020 | 1397 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2016 | 0.120 |
Why?
|
Protein Binding | 2 | 2022 | 9559 | 0.110 |
Why?
|
Mutation, Missense | 1 | 2022 | 2515 | 0.110 |
Why?
|
Proteomics | 3 | 2020 | 3248 | 0.110 |
Why?
|
Oligopeptides | 1 | 2018 | 1236 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 441 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2020 | 752 | 0.110 |
Why?
|
Nuclear Receptor Coactivators | 2 | 2022 | 60 | 0.110 |
Why?
|
Pyridines | 2 | 2021 | 2846 | 0.110 |
Why?
|
Tumor Cells, Cultured | 4 | 2020 | 6484 | 0.110 |
Why?
|
Sulfur | 2 | 2022 | 166 | 0.110 |
Why?
|
Biological Availability | 2 | 2022 | 392 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2022 | 4823 | 0.110 |
Why?
|
Gene Amplification | 1 | 2016 | 1078 | 0.100 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3574 | 0.100 |
Why?
|
Transcription Factors | 5 | 2022 | 11953 | 0.100 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 742 | 0.100 |
Why?
|
Genome, Human | 3 | 2016 | 4471 | 0.100 |
Why?
|
Phosphorylation | 1 | 2022 | 8658 | 0.100 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 933 | 0.100 |
Why?
|
Mice, Nude | 4 | 2021 | 3801 | 0.100 |
Why?
|
Structure-Activity Relationship | 3 | 2020 | 3206 | 0.090 |
Why?
|
Apoptosis | 3 | 2021 | 9973 | 0.090 |
Why?
|
Weight Loss | 1 | 2020 | 2515 | 0.090 |
Why?
|
Nucleic Acid Hybridization | 3 | 2005 | 1435 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3770 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2017 | 2985 | 0.080 |
Why?
|
Iron | 3 | 2022 | 1735 | 0.080 |
Why?
|
p21-Activated Kinases | 1 | 2008 | 128 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2533 | 0.080 |
Why?
|
Gene Expression | 2 | 2016 | 7954 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1894 | 0.080 |
Why?
|
Male | 19 | 2021 | 350324 | 0.080 |
Why?
|
rho GTP-Binding Proteins | 1 | 2008 | 301 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2005 | 4040 | 0.080 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 333 | 0.080 |
Why?
|
Nanoparticles | 1 | 2018 | 1900 | 0.080 |
Why?
|
Aged | 9 | 2021 | 162448 | 0.070 |
Why?
|
Computational Biology | 3 | 2021 | 3571 | 0.070 |
Why?
|
Prognosis | 6 | 2023 | 29005 | 0.070 |
Why?
|
Pyrimidinones | 2 | 2020 | 373 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2968 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2789 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3898 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 3063 | 0.070 |
Why?
|
Stromal Cells | 2 | 2021 | 1338 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 8896 | 0.070 |
Why?
|
Molecular Structure | 2 | 2020 | 1950 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2020 | 13213 | 0.070 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5947 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2021 | 8047 | 0.070 |
Why?
|
Female | 19 | 2021 | 377204 | 0.060 |
Why?
|
Pancreatectomy | 2 | 2020 | 824 | 0.060 |
Why?
|
Cell Death | 2 | 2021 | 1724 | 0.060 |
Why?
|
Pyridones | 2 | 2020 | 692 | 0.060 |
Why?
|
Genes, p53 | 1 | 2006 | 764 | 0.060 |
Why?
|
Respiration | 1 | 1990 | 1670 | 0.060 |
Why?
|
Genome | 2 | 2017 | 1754 | 0.060 |
Why?
|
Homozygote | 2 | 2006 | 1856 | 0.060 |
Why?
|
Down-Regulation | 2 | 2021 | 3066 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2004 | 438 | 0.060 |
Why?
|
Claudins | 1 | 2023 | 121 | 0.060 |
Why?
|
Middle Aged | 10 | 2021 | 214639 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22665 | 0.050 |
Why?
|
Gene Deletion | 3 | 2006 | 2824 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2556 | 0.050 |
Why?
|
Colon | 2 | 2020 | 1759 | 0.050 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2022 | 115 | 0.050 |
Why?
|
Genes, p16 | 1 | 2001 | 160 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 3689 | 0.050 |
Why?
|
Chromosomes | 1 | 2004 | 597 | 0.050 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 2020 | 22 | 0.050 |
Why?
|
Spliceosomes | 1 | 2021 | 107 | 0.050 |
Why?
|
Integrases | 1 | 2003 | 548 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9375 | 0.050 |
Why?
|
Calpain | 1 | 2021 | 153 | 0.050 |
Why?
|
Fibroblasts | 3 | 2014 | 4233 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 422 | 0.050 |
Why?
|
Alleles | 3 | 2018 | 7099 | 0.050 |
Why?
|
Micronucleus Tests | 1 | 2019 | 22 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15603 | 0.050 |
Why?
|
Half-Life | 1 | 2021 | 674 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2020 | 15059 | 0.050 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 124 | 0.050 |
Why?
|
Ferritins | 1 | 2022 | 581 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58323 | 0.050 |
Why?
|
Acetamides | 1 | 2021 | 252 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9849 | 0.050 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 172 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7095 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4296 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 7015 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4266 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1097 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2020 | 425 | 0.040 |
Why?
|
Heart Rate | 1 | 1990 | 4097 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 158 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 751 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 684 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2022 | 2824 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 408 | 0.040 |
Why?
|
Morpholines | 1 | 2021 | 572 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9730 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4262 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 744 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 81 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 560 | 0.040 |
Why?
|
Lipid Peroxides | 1 | 2017 | 64 | 0.040 |
Why?
|
Adult | 7 | 2021 | 212266 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 622 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3681 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 207 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1808 | 0.040 |
Why?
|
Tubulin | 1 | 2021 | 759 | 0.040 |
Why?
|
Bacteroides | 1 | 2017 | 183 | 0.040 |
Why?
|
Phenotype | 3 | 2023 | 16311 | 0.040 |
Why?
|
Ribosomes | 1 | 2020 | 502 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 11940 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 962 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2019 | 714 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7885 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1854 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2021 | 702 | 0.040 |
Why?
|
Inflammation | 3 | 2021 | 10081 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 691 | 0.040 |
Why?
|
Cytoplasm | 1 | 2021 | 1625 | 0.040 |
Why?
|
Electrocardiography | 1 | 1990 | 6386 | 0.040 |
Why?
|
Ion Channels | 1 | 2021 | 1078 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2017 | 190 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 831 | 0.040 |
Why?
|
Viral Proteins | 1 | 2003 | 1959 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2020 | 760 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2018 | 1801 | 0.040 |
Why?
|
Citric Acid Cycle | 1 | 2017 | 231 | 0.040 |
Why?
|
Intestinal Diseases | 1 | 2020 | 511 | 0.040 |
Why?
|
Survival Analysis | 2 | 2020 | 10499 | 0.040 |
Why?
|
Immunity | 1 | 2021 | 976 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2020 | 19910 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1904 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 919 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1357 | 0.030 |
Why?
|
Standard of Care | 1 | 2018 | 522 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2019 | 1695 | 0.030 |
Why?
|
Autophagy | 1 | 2022 | 1314 | 0.030 |
Why?
|
Drug Design | 1 | 2020 | 1099 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 798 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 386 | 0.030 |
Why?
|
Mesoderm | 1 | 2017 | 723 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 40029 | 0.030 |
Why?
|
Organizational Policy | 1 | 2016 | 439 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 580 | 0.030 |
Why?
|
Pancreas | 1 | 2020 | 1683 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1373 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2613 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2021 | 2008 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3524 | 0.030 |
Why?
|
Pyrroles | 1 | 2019 | 1172 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 810 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5397 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1177 | 0.030 |
Why?
|
Cadherins | 1 | 2017 | 913 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3493 | 0.030 |
Why?
|
Models, Biological | 2 | 2020 | 9809 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 714 | 0.030 |
Why?
|
Monocytes | 1 | 2021 | 2620 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19537 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2014 | 999 | 0.030 |
Why?
|
Adenoma | 1 | 2021 | 2119 | 0.030 |
Why?
|
Histones | 1 | 2021 | 2551 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2019 | 3250 | 0.030 |
Why?
|
Medical Oncology | 1 | 2023 | 2118 | 0.030 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 535 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4312 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 5074 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 6035 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1761 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1646 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 1957 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13215 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6722 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4384 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5467 | 0.020 |
Why?
|
Base Sequence | 1 | 2020 | 13179 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3374 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 3004 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3800 | 0.020 |
Why?
|
Homeostasis | 1 | 2019 | 3332 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3638 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3034 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2594 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4455 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 14161 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 1941 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 976 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1606 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10284 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4378 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4919 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4095 | 0.020 |
Why?
|
Proteins | 1 | 2001 | 6070 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12456 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7960 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5064 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40875 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2995 | 0.020 |
Why?
|
Cytogenetics | 1 | 2005 | 213 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18199 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11655 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 322 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11689 | 0.020 |
Why?
|
Rats | 1 | 2020 | 24860 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9377 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 62004 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2686 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12535 | 0.010 |
Why?
|
Urethane | 1 | 2001 | 38 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4103 | 0.010 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2001 | 65 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20731 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8350 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12305 | 0.010 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2005 | 671 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1092 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1104 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2555 | 0.010 |
Why?
|
Carcinogens | 1 | 2001 | 452 | 0.010 |
Why?
|
Melanoma | 1 | 2017 | 5250 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 16576 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2004 | 1773 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2005 | 2648 | 0.010 |
Why?
|
Heart | 1 | 1990 | 4315 | 0.010 |
Why?
|
Thymus Gland | 1 | 2001 | 1317 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39300 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2005 | 2538 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1749 | 0.010 |
Why?
|
Trans-Activators | 1 | 2005 | 3047 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 10605 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2883 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6274 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 51315 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4699 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3485 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 72443 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2005 | 5102 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2005 | 3994 | 0.010 |
Why?
|
Child | 1 | 1990 | 74468 | 0.000 |
Why?
|
Adolescent | 1 | 1990 | 85155 | 0.000 |
Why?
|